Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To reduce antiparkinsonian medication in parkinsonian patients with bilateral high frequency subthalamic nucleus (STN) stimulation. BACKGROUND: Parkinsonian syndromes are characterized by hyperactivity of the STN. Preliminary data indicate that functional inactivation of the STN may reduce the requirement for dopaminergic therapy in PD. METHODS: Bilateral quadripolar leads were implanted stereotactically in the STN of seven patients with advanced PD (mean age, 57.4 years; mean disease duration, 15.4 years). High-frequency stimulation was applied for 24 hours a day. Following implantation, antiparkinsonian medication was reduced to the minimum possible and stimulation was gradually increased. The patients were evaluated in the practically defined "off" and "on" conditions using the Unified Parkinson's Disease Rating Scale (UPDRS) and the Schwab & England scale. The average follow-up was 16.3+/-7.6 months. A battery of neuropsychological tests was applied before and 9 months after the implant. RESULTS: Parkinsonian features improved in all patients--the greatest change seen in rigidity, then tremor, followed by bradykinesia. Compared with the presurgical condition, off-drug UPDRS motor scores improved by 41.9% on the last visit (p = 0.0002), UPDRS activities of daily living (ADL) scores improved by 52.2% (p = 0.0002), and the Schwab & England scale score improved by 213% (p = 0.0002). The levodopa-equivalent daily dose was reduced by 65%. Night sleep improved in all patients due to increased mobility at night, and in five patients insomnia was resolved. All patients gained weight after surgery and their appetite increased. The mean weight gain at the last follow-up was 13% compared with before surgery. During the last visit, the stimulation amplitude was 2.9+/-0.5 V and the total energy delivered per patient averaged 2.7+/-1.4 W x10(-6). The results of patient self-assessment scales indicated a marked improvement in five patients and a moderate improvement in the other two. The neuropsychological data showed no changes. Side effects were mild and tolerable. In all cases, a tradeoff between the optimal voltage and the severity of side effects made it possible to control parkinsonian signs effectively. The most marked side effects directly related to STN stimulation consisted of ballistic or choreic dyskinesias of the neck and the limbs elicited by contralateral STN stimulation above a given threshold voltage, which varied depending on the individual. CONCLUSIONS: Parkinsonian signs can be controlled by bilateral high-frequency STN stimulation. The procedure is well tolerated. On-state dyskinesias were greatly reduced, probably due to the reduction of total antiparkinsonian medication. Bilateral high-frequency STN stimulation compensated for drug reduction and elicited dyskinesias, which differ from those observed following dopaminergic medication. ADL improved significantly, suggesting that some motor tasks performed during everyday chores, and that are not taken into account in the UPDRS motor score, also improved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853
Aromatic Amino Acids and Modification of Parkinsonism
Cotzias, G. C., Van Woert, M. H., & Schiffer, L. M. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760703 · Cited by 1,494
Benabid, A. L., Pollak, P., Gao, D., Hoffmann, D., Limousin, P., Gay, E., Payen, I., & Benazzouz, A. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.84.2.0203 · Cited by 1,134
Core assessment program for intracerebral transplantations (CAPIT)
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., & Watts, R. (1992) · Movement Disorders · doi:10.1002/mds.870070103 · Cited by 1,008
Atlas for Stereotaxy of the Human Brain
Schaltenbrand, G., & Wahren, W. (1977) · Medical Entomology and Zoology · Cited by 955
Kumar, R., Lozano, A. M., Kim, Y. J., Hutchison, W. D., Sime, E., Halket, E., & Lang, A. E. (1998) · Neurology · doi:10.1212/wnl.51.3.850 · Cited by 634
Cited by
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,265
Stefani, A., Lozano, A. M., Peppe, A., Stanzione, P., Galati, S., Tropepi, D., Pierantozzi, M., Brusa, L., Scarnati, E., & Mazzone, P. (2007) · Brain · doi:10.1093/brain/awl346 · Cited by 807
Funkiewiez, A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2002.009803 · Cited by 572
Behavioural disorders, Parkinson's disease and subthalamic stimulation
Houeto, J. L. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.701 · Cited by 500
Parsons, T. D., Rogers, S. A., Braaten, A. J., Woods, S. P., & Tröster, A. I. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70475-6 · Cited by 500
The impact on Parkinson’s disease of electrical parameter settings in STN stimulation
Moro, E., Esselink, R. J. A., Xie, J., Hommel, M., Benabid, A. L., & Pollak, P. (2002) · Neurology · doi:10.1212/wnl.59.5.706 · Cited by 500
Self-citationTen-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation
Castrioto, A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.182 · Cited by 455
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants
Fasano, A., Romito, L. M., Daniele, A., Piano, C., Zinno, M., Bentivoglio, A. R., & Albanese, A. (2010) · Brain · doi:10.1093/brain/awq221 · Cited by 429
Self-citationClinical predictive factors of subthalamic stimulation in Parkinson's disease
Welter, M. L., Houeto, J. L., Tezenas du Montcel, S., Mesnage, V., Bonnet, A. M., Pillon, B., Arnulf, I., Pidoux, B., Dormont, D., Cornu, P., et al. (2002) · Brain · doi:10.1093/brain/awf050 · Cited by 426
The functional role of the subthalamic nucleus in cognitive and limbic circuits
Temel, Y., Blokland, A., Steinbusch, H. W. M., & Visser-Vandewalle, V. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.09.005 · Cited by 426
Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD
Volkmann, J., Allert, N., Voges, J., Weiss, P. H., Freund, H.-J., & Sturm, V. (2001) · Neurology · doi:10.1212/wnl.56.4.548 · Cited by 425
Temel, Y., Kessels, A., Tan, S., Topdag, A., Boon, P., & Visser-Vandewalle, V. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.01.004 · Cited by 424
Mazzone, P., Lozano, A., Stanzione, P., Galati, S., Scarnati, E., Peppe, A., & Stefani, A. (2005) · NeuroReport · doi:10.1097/01.wnr.0000187629.38010.12 · Cited by 423
Starr, P. A., Christine, C. W., Theodosopoulos, P. V., Lindsey, N., Byrd, D., Mosley, A., & Marks, W. J. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.2.0370 · Cited by 415
Deep brain stimulation: Neuropsychological and neuropsychiatric issues
Voon, V., Kubu, C., Krack, P., Houeto, J.-L., & Tröster, A. I. (2006) · Movement Disorders · doi:10.1002/mds.20963 · Cited by 403
Ma, K., Xiong, N., Shen, Y., Han, C., Liu, L., Zhang, G., Wang, L., Guo, S., Guo, X., Xia, Y., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00001 · Cited by 379
Kleiner-Fisman, G., Fisman, D. N., Sime, E., Saint-Cyr, J. A., Lozano, A. M., & Lang, A. E. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.3.0489 · Cited by 351
Gross, R. E., Krack, P., Rodriguez-Oroz, M. C., Rezai, A. R., & Benabid, A.-L. (2006) · Movement Disorders · doi:10.1002/mds.20960 · Cited by 324
Subthalamic DBS replaces levodopa in Parkinson’s disease: Two-year follow-up
Vingerhoets, F. J. G., Villemure, J.-G., Temperli, P., Pollo, C., Pralong, E., & Ghika, J. (2002) · Neurology · doi:10.1212/wnl.58.3.396 · Cited by 314
Deep brain stimulation: Postoperative issues
Deuschl, G., Herzog, J., Kleiner-Fisman, G., Kubu, C., Lozano, A. M., Lyons, K. E., Rodriguez-Oroz, M. C., Tamma, F., Tröster, A. I., Vitek, J. L., et al. (2006) · Movement Disorders · doi:10.1002/mds.20957 · Cited by 313
Deep brain stimulation: Preoperative issues
Lang, A. E., Houeto, J.-L., Krack, P., Kubu, C., Lyons, K. E., Moro, E., Ondo, W., Pahwa, R., Poewe, W., Tröster, A. I., et al. (2006) · Movement Disorders · doi:10.1002/mds.20955 · Cited by 308
Self-citationVoges, J., Volkmann, J., Allert, N., Lehrke, R., Koulousakis, A., Freund, H.-J., & Sturm, V. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.96.2.0269 · Cited by 300
Deep Brain Stimulation for the Treatment of Parkinson’s Disease
Volkmann, J. (2004) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200401000-00003 · Cited by 298
Two‐year follow‐up of subthalamic deep brain stimulation in Parkinson's disease
Herzog, J., Volkmann, J., Krack, P., Kopper, F., Pötter, M., Lorenz, D., Steinbach, M., Klebe, S., Hamel, W., Schrader, B., et al. (2003) · Movement Disorders · doi:10.1002/mds.10518 · Cited by 296
Saint-Cyr, J. A., Hoque, T., Pereira, L. C. M., Dostrovsky, J. O., Hutchison, W. D., Mikulis, D. J., Abosch, A., Sime, E., Lang, A. E., & Lozano, A. M. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.5.1152 · Cited by 291
Chronic pain in Parkinson's disease: The cross‐sectional French DoPaMiP survey
Nègre‐Pagès, L., Regragui, W., Bouhassira, D., Grandjean, H., & Rascol, O. (2008) · Movement Disorders · doi:10.1002/mds.22142 · Cited by 287
Breit, S., Schulz, J. B., & Benabid, A.-L. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0936-0 · Cited by 273
Postoperative management of subthalamic nucleus stimulation for Parkinson's disease
Krack, P., Fraix, V., Mendes, A., Benabid, A.-L., & Pollak, P. (2002) · Movement Disorders · doi:10.1002/mds.10163 · Cited by 267
Romito, L. M., Raja, M., Daniele, A., Contarino, M. F., Bentivoglio, A. R., Barbier, A., Scerrati, M., & Albanese, A. (2002) · Movement Disorders · doi:10.1002/mds.10265 · Cited by 266
Self-citationUnilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial
Esselink, R. A. J., de Bie, R. M. A., de Haan, R. J., Lenders, M. W. P. M., Nijssen, P. C. G., Staal, M. J., Smeding, H. M. M., Schuurman, P. R., Bosch, D. A., & Speelman, J. D. (2004) · Neurology · doi:10.1212/01.wnl.0000103235.12621.c3 · Cited by 254
Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease
Herzog, J., Fietzek, U., Hamel, W., Morsnowski, A., Steigerwald, F., Schrader, B., Weinert, D., Pfister, G., Müller, D., Mehdorn, H. M., et al. (2004) · Movement Disorders · doi:10.1002/mds.20056 · Cited by 253
Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease
Kim, J.-S., & Sung, H.-Y. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15008 · Cited by 76
Rabelo, A. G., Neves, L. P., Paixão, A. P. S., Oliveira, F. H. M., de Souza, L. A. P. S., Vieira, M. F., Pereira, A. A., & Andrade, A. O. (2017) · Annals of Biomedical Engineering · doi:10.1007/s10439-017-1908-3 · Cited by 46
A Systematic Review of Neuromodulation Treatment Effects on Suicidality
Kucuker, M. U., Almorsy, A. G., Sonmez, A. I., Ligezka, A. N., Doruk Camsari, D., Lewis, C. P., & Croarkin, P. E. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.660926 · Cited by 25
Metadata
- Authors
- Moro, E., Scerrati, M., Romito, L. M. A., Roselli, R., Tonali, P., & Albanese, A.
- Venue
- Neurology
- Published
- 1999-07
- Volume
- 53
- Issue
- 1
- Pages
- 85-85
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2045116961
- Cited by
- 420
- References
- 22
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.